Daniel Lynch

Insider Reports History

Entity
Individual
Signature
/s/ Francis I. Perier, Jr. as Attorney-in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Lynch:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SpringWorks Therapeutics, Inc. Director Common Stock 306K $14.6M $47.62 May 16, 2024 Direct
2seventy bio, Inc. Director Common Stock 21.1K $79K $3.75 Jun 13, 2023 Direct
2seventy bio, Inc. Director Stock Option (right to buy) 16.9K $66.4K $3.93 Jun 13, 2023 Direct
bluebird bio, Inc. Director Common Stock 7.96K $11.4K $1.43 Nov 11, 2021 Direct
SpringWorks Therapeutics, Inc. Director Stock Option (Right to Buy) 12.2K May 16, 2024 Direct
bluebird bio, Inc. Director Stock Option (right to buy) 0 Nov 11, 2021 Direct

Insider Reports Filed by Daniel Lynch

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SWTX SpringWorks Therapeutics, Inc. May 16, 2024 2 $0 4 May 17, 2024 Director
TSVT 2seventy bio, Inc. Jun 13, 2023 2 $0 4 Jun 15, 2023 Director
SWTX SpringWorks Therapeutics, Inc. May 24, 2023 2 $0 4 May 25, 2023 Director
TSVT 2seventy bio, Inc. Jun 8, 2022 2 $0 4 Jun 9, 2022 Director
SWTX SpringWorks Therapeutics, Inc. May 19, 2022 2 $0 4 May 20, 2022 Director
BLUE bluebird bio, Inc. Nov 11, 2021 10 $0 4 Nov 17, 2021 Director
TSVT 2seventy bio, Inc. Nov 11, 2021 10 $0 4 Nov 16, 2021 Director
XLO Xilio Therapeutics, Inc. Oct 21, 2021 0 $0 3 Oct 21, 2021 Director, 10%+ Owner
TSVT 2seventy bio, Inc. Oct 18, 2021 0 $0 3 Oct 18, 2021 Director
BLUE bluebird bio, Inc. Jun 15, 2021 2 $0 4 Jun 17, 2021 Director
SWTX SpringWorks Therapeutics, Inc. May 20, 2021 2 $0 4 May 21, 2021 Director